Results 181 to 190 of about 31,390 (228)

Serum CD73 activity as a biomarker of hypoxemia in COVID-19 patients. [PDF]

Sci Rep
Le Borgne P, Bilbault P, Clere-Jehl R, Favre J, Lefebvre F, Ubeaud-Séquier G, Ghazouani FE, Demiselle J, Toti F, Meziani F, Kauffenstein G.   +10 more
europepmc   +1 more source

Small Subset, Big Impact: Regulatory Function of γδ T Cells in Arteriogenesis. [PDF]

Cells
Wimmer KS, Baur C, Kübler M, Arnholdt C, Kumaraswami K, Heim F, Elbs K, Rohrmoser MR, Merkus D, Deindl E.   +9 more
europepmc   +1 more source

CD39 polymorphism enables lung thrombosis in sickle cell disease. [PDF]

Nat Commun
Brzoska T, Kaminski TW, Katoch O, Menchikova EV, Alagbe AE, Tashbook SE, Tofovic SP, Jonassaint JC, St Croix CM, Watkins SC, Howe S, Field JJ, Seyerle AA, Pradhan-Sundd T, Laurie C, Pankratz ND, Smith NL, Goode EL, Pankow JS, Kooperberg C, Kato GJ, Zhang Y, Novelli EM, Gladwin MT, Jackson EK, Nouraie SM, Sundd P.   +26 more
europepmc   +1 more source

CD39⁺PD-1⁺ regulatory T cells in melanoma: key drivers of systemic immunosuppression and prognostic biomarkers. [PDF]

Front Oncol
Qiao G, He H, Wang X.
europepmc   +1 more source

Nucleotide signaling in neutrophils: a key player in cancer dynamics. [PDF]

Purinergic Signal
da Silva JLG, Sévigny J, Leal DBR.
europepmc   +1 more source

SNP rs10748643 determines CD39 expression in T and NK cells through altering NFIC binding affinity rather than interfering with RNA splicing. [PDF]

Front Immunol
Gan C, Wu Q, Goronzy JJ, Zhang Y, Li L, Sheng H, Fang F.   +6 more
europepmc   +1 more source

Resistance exercise exerts anti-hypertensive effects and downregulates NTPDase/CD39 and ecto-5'-nucleotidase/CD73 expression in patients with chronic kidney disease undergoing hemodialysis. [PDF]

Purinergic Signal
Dalagnol AMK, Franscescon F, Bianchini MC, Puhle JG, da Silva KET, Santos HM, de Oliveira Maciel SFV, de Resende E Silva DT.   +7 more
europepmc   +1 more source

CD39 and control of cellular immune responses [PDF]

Purinergic Signalling, 2007
CD39 is the cell surface-located prototypic member of the ecto-nucleoside triphosphate diphosphohydrolase (E-NTPDase) family. Biological actions of CD39 are a consequence (at least in part) of the regulated phosphohydrolytic activity on extracellular nucleotides.
Simon C Robson, David Friedman, Wenda Gao   +2 more
exaly   +14 more sources

CD39 Regulation and Functions in T Cells [PDF]

International Journal of Molecular Sciences, 2021
CD39 is an enzyme which is responsible, together with CD73, for a cascade converting adenosine triphosphate into adenosine diphosphate and cyclic adenosine monophosphate, ultimately leading to the release of an immunosuppressive form of adenosine in the tumor microenvironment.
Vincenzo Barnaba, Eleonora Timperi, Barnaba Vincenzo   +2 more
exaly   +7 more sources

Implications of CD39 in immune-related diseases

International Immunopharmacology, 2020
Extracellular adenosine triphosphate (eATP) mediates pro-inflammatory responses by recruiting and activating inflammatory cells. CD39 can hydrolyze eATP into adenosine monophosphate (AMP), while CD73 can convert AMP into the immunosuppressive nucleoside adenosine (ADO).
Chunxia Li
exaly   +3 more sources